Antitumor compositions containing taxane derivatives
First Claim
Patent Images
1. A pharmaceutical composition comprised of the compound of formula 1:
- or a derivatve thereof, and at least one of an alkylating agent, an antimetabolite, a spindle poison, an epidophyllotoxin, an antibiotic, an enzyme, a topoisomerase inhibitor, a platinum coordination complex, a biological response modifier or a growth factor inhibitor.
1 Assignment
0 Petitions
Accused Products
Abstract
A pharmaceutical composition comprised of acetocyclopropyl taxotere or a derivatve thereof, and at least one of an alkylating agent, an antimetabolite, a spindle poison, an epidophyllotoxin, an antibiotic, an enzyme, a topoisomerase inhibitor, a platinum coordination complex, a biological response modifier or a growth factor inhibitor is described.
42 Citations
19 Claims
-
1. A pharmaceutical composition comprised of the compound of formula 1:
-
or a derivatve thereof, and at least one of an alkylating agent, an antimetabolite, a spindle poison, an epidophyllotoxin, an antibiotic, an enzyme, a topoisomerase inhibitor, a platinum coordination complex, a biological response modifier or a growth factor inhibitor. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A pharmaceutical composition having therapeutic synergy in the treatment of neoplastic disease comprising a compound of the formula:
-
and doxorubicin. - View Dependent Claims (14, 15, 16, 17, 18)
-
-
11. A pharmaceutical composition having therapeutic synergy in the treatment of neoplastic disease comprising a compound of the formula:
-
and navelbine.
-
-
12. A pharmaceutical composition having therapeutic synergy in the treatment of neoplastic disease comprising a compound of the formula:
-
and cisplatin. - View Dependent Claims (19)
-
-
13. A pharmaceutical composition having therapeutic synergy in the treatment of neoplastic disease comprising a compound of the formula:
-
and CPT 11.
-
Specification